University of Birmingham clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   FARGO · FAecal Microbiota Transplantation in primaRy sclerosinG…FARGO · FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

   Primary completion pushed from Apr 30, 2026 to Sep 30, 2027

   Also in this update: Study completion pushed from Feb 28, 2027 to Sep 30, 2027

   University of Birmingham·Phase 2· NCT06286709· Registry history of NCT06286709 on ClinicalTrials.gov (opens the registry)

   Updated Sep 24, 2026

2. Notable

   THROMBO-STOP · Apixaban to Prevent Venous Thromboembolism in…THROMBO-STOP · Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

   Recruitment opened

   Also in this update: Primary completion pushed from Sep 30, 2029 to Oct 30, 2029; Trial sites expanded: 1 → 8 locations

   University of Birmingham·Phase 3· NCT07160686· Registry history of NCT07160686 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.